EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Directing B7-H3 chimeric antigen receptor T cell homing through IL-8 induces potent antitumor activity against pediatric sarcoma

Jessica A Lake iD, Elena Woods, Eric Hoffmeyer, Kristin L Schaller, Joselyn Cruz-Cruz, Joseph Fernandez, Dejene Tufa, Benjamin Kooiman, Spencer C Hall, Dallas Jones, Masanori Hayashi, Michael R Verneris iD

Journal for ImmunoTherapy of Cancer · 2024

DOI: 10.1136/jitc-2024-009221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2024. Verfasst von Jessica A Lake und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology, Oncology, BMT, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: B7 Antigens, Interleukin-8, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advances in pediatric oncology have occurred for some cancers; however, new therapies for sarcoma have been inadequate. Cellular immunotherapy using chimeric antigen receptor (CAR) T cells has shown dramatic benefits in leukemia, lymphoma, and multiple myeloma but has been far less successful in pediatric solid tumors such as rhabdomyosarcoma (RMS) and osteosarcoma (OS). Balancing issues of “on-target, off-tumor toxicity”, investigators have identified B7-H3 as a broadly expressed tumor antigen with otherwise restricted expression on normal tissues. We hypothesized that rapid homing via a chemokine receptor and CAR engagement through B7-H3 would enhance CAR T cell efficacy in solid tumors.

Methods

We generated B7-H3 CAR T cells that also express the Interleukin-8 (IL-8) receptor, CXCR2. Cytokine production, flow cytometry, Seahorse assays and RNA sequencing were used to compare the B7-H3 CXCR2 (BC2) CAR T cells with B7-H3 CAR T cells. We developed an IL-8 overexpressing human RMS mouse model to test homing and cytotoxicity in vivo.

Results

We demonstrate that IL-8 is expressed by RMS and OS and expression significantly increases after radiation. Overexpression of an IL-8 receptor, CXCR2, on B7-H3 CAR T cells enhances homing into IL-8 expressing tumors, augments T cell metabolism and leads to significant tumor regression.

Conclusion

These findings warrant further investigation into the use of BC2 CAR T cells as a treatment for patients with RMS, OS and other B7-H3-expressing, IL-8 producing solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7 AntigensInterleukin-8Receptors, Chimeric AntigenHumansAnimalsMiceImmunotherapy, AdoptiveSarcomaCell Line, TumorChildT-LymphocytesXenograft Model Antitumor Assays

Stichwörter der Autor:innen

Adoptive cell therapy - ACTChimeric antigen receptor - CARImmunotherapySolid tumor

Substanzen

B7 AntigensInterleukin-8Receptors, Chimeric AntigenCD276 protein, human

Autor:innen und Institutionen

  • Department of Pediatric Hematology, Oncology, BMT, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Pediatric Hematology, Oncology, BMT, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA MICHAEL.VERNERIS@CUANSCHUTZ.EDU.

ORCID-Profile: Jessica A Lake, Michael R Verneris

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • Salah Foundation
  • National Institutes of Health
  • Colorado Clinical and Translational Sciences Institute

Zitieren

APA

Lake, J. A., Woods, E., Hoffmeyer, E., Schaller, K. L., Cruz-Cruz, J., Fernandez, J., Tufa, D., Kooiman, B., Hall, S. C., Jones, D., Hayashi, M., & Verneris, M. R. (2024). Directing B7-H3 chimeric antigen receptor T cell homing through IL-8 induces potent antitumor activity against pediatric sarcoma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-009221

Vancouver

Lake JA, Woods E, Hoffmeyer E, Schaller KL, Cruz-Cruz J, Fernandez J, et al. Directing B7-H3 chimeric antigen receptor T cell homing through IL-8 induces potent antitumor activity against pediatric sarcoma. Journal for ImmunoTherapy of Cancer. 2024. doi:10.1136/jitc-2024-009221

BibTeX
@article{Lake2024,
  author = {Lake, Jessica A and Woods, Elena and Hoffmeyer, Eric and Schaller, Kristin L and Cruz-Cruz, Joselyn and Fernandez, Joseph and Tufa, Dejene and Kooiman, Benjamin and Hall, Spencer C and Jones, Dallas and Hayashi, Masanori and Verneris, Michael R},
  title = {Directing B7-H3 chimeric antigen receptor T cell homing through IL-8 induces potent antitumor activity against pediatric sarcoma},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2024},
  doi = {10.1136/jitc-2024-009221}
}
Kostenlos starten →